Medicare Enrolled
Dr. Saeed Khan, MD
Pulmonary Disease · Schenectady, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Saeed Khan is a pulmonary disease specialist in Schenectady, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 1,084 Medicare services across 658 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khan received a total of $7,698 from 39 pharmaceutical and/or device companies across 394 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 37% volume in NY
$7,698 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,084
Medicare services
Top 37% in NY for pulmonary disease
658
Unique beneficiaries
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~57 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
419 | $93 | $197 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
343 | $90 | $207 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $136 | $378 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
39 | $101 | $514 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
29 | $478 | $2,899 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
26 | $167 | $399 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
22 | $41 | $95 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
22 | $44 | $97 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
21 | $29 | $124 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
19 | $462 | $2,520 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
19 | $90 | $207 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $121 | $272 |
| New patient office visit, complex (60-74 min) | 12 | $138 | $385 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
11 | $46 | $511 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,698
Total received (2018-2024)
Avg $1,100/year across 7 years
Top 22% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
394
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,666 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$32 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,688
2023
$1,467
2022
$1,155
2021
$687
2020
$1,011
2019
$899
2018
$792
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$415
AstraZeneca Pharmaceuticals LP
$332
HARMONY BIOSCIENCES LLC
$179
ABBVIE INC.
$166
Regeneron Healthcare Solutions, Inc.
$166
GENZYME CORPORATION
$110
Baxter Healthcare
$77
Actelion Pharmaceuticals US, Inc.
$50
Insmed, Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Philips North America LLC
$27
Novartis Pharmaceuticals Corporation
$25
Amgen Inc.
$22
Pulmonx Corporation
$21
Electromed, Inc.
$21
Merck Sharp & Dohme LLC
$18
Top 3 companies account for 54.8% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,063
AstraZeneca Pharmaceuticals LP
$1,169
Boehringer Ingelheim Pharmaceuticals, Inc.
$526
Regeneron Healthcare Solutions, Inc.
$395
GENZYME CORPORATION
$348
Janssen Pharmaceuticals, Inc
$305
Harmony Biosciences LLC
$295
ABBVIE INC.
$252
Philips Electronics North America Corporation
$245
Novartis Pharmaceuticals Corporation
$216
HARMONY BIOSCIENCES LLC
$199
Genentech USA, Inc.
$186
PORTOLA PHARMACEUTICALS, INC.
$156
Actelion Pharmaceuticals US, Inc.
$155
Takeda Pharmaceuticals U.S.A., Inc.
$150
Grifols USA, LLC
$128
Electromed, Inc.
$126
Baxter Healthcare
$91
Merck Sharp & Dohme LLC
$86
United Therapeutics Corporation
$53
Pulmonx Corporation
$50
Insmed, Inc.
$49
Mallinckrodt LLC
$49
Shionogi Inc
$46
Teva Pharmaceuticals USA, Inc.
$40
Merck Sharp & Dohme Corporation
$38
Philips North America LLC
$27
Veran Medical Technologies, Inc.
$27
PFIZER INC.
$27
Sunovion Pharmaceuticals Inc.
$26
CSL Behring
$24
Gilead Sciences, Inc.
$23
Shire North American Group Inc
$23
Amgen Inc.
$22
Alexion Pharmaceuticals, Inc.
$20
Circassia Pharmaceuticals Inc
$16
E.R. Squibb & Sons, L.L.C.
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
Vapotherm Inc
$14
Top 3 companies account for 48.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · Arikayce · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · CINQAIR · DUPIXENT · ELIQUIS · Esbriet · FARXIGA · FASENRA · Fetroja · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · Hizentra · LOKELMA · LONHALA MAGNAIR · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENITRAM · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Spin · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · Ultomiris · VAPOTHERM · WAKIX · Wakix · XARELTO · XOLAIR · Xolair · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
37
Per 100K population
23.2
County median income
$76,989
Nearest hospital
ELLIS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Khan performed 419 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $7,698 from 39 companies across 394 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other pulmonary diseases in Schenectady?
Dr. Khan's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Schenectady
Browse pulmonary diseases in Schenectady ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology